Viewing Study NCT06658834


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-01-07 @ 12:11 PM
Study NCT ID: NCT06658834
Status: RECRUITING
Last Update Posted: 2024-10-26
First Post: 2024-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IIT2024046
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View